MiR103a-3p and MiR107 Are Related to Adaptive Coping in a Cluster of Fibromyalgia Patients

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Sep 17

PMID 32941517

Citations 8

Authors

Alexandra Braun

Dimitar Evdokimov

Johanna Frank

Claudia Sommer

Nurcan Uceyler

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNA (miRNA) mainly inhibit post-transcriptional gene expression of specific targets and may modulate disease severity.

Objective: We aimed to identify miRNA signatures distinguishing patient clusters with fibromyalgia syndrome (FMS).

Subjects And Methods: We previously determined four FMS patient clusters labelled "maladaptive", "adaptive", "vulnerable", and "resilient". Here, we cluster-wise assessed relative gene expression of miR103a-3p, miR107, miR130a-3p, and miR125a-5p in white blood cell (WBC) RNA of 31 FMS patients and 16 healthy controls. Sum scores of pain-, stress-, and resilience-related questionnaires were correlated with miRNA relative gene expression. A cluster-specific speculative model of a miRNA-mediated regulatory cycle was proposed, and its potential targets verified by the online tool "target scan human".

Results: One-way ANOVA revealed lower gene expression of miR103a-3p, miR107, and miR130a-3p in FMS patients compared to controls (p < 0.05). Follow-up post-hoc tests indicated the highest peak of gene expression of miR103a-3p for the adaptive cluster (p < 0.05), i.e. in patients with low disability in all symptom categories. Gene expression of miR103a-3p correlated with FMS related disability and miR107 with the score "physical abuse" of the trauma questionnaire (p < 0.05). Target scan identified sucrose non-fermentable serine/threonine protein kinase, nuclear factor kappa-b, cyclin dependent kinase, and toll-like receptor 4 as genetic targets of the miR103a/107 miRNA family.

Conclusion: We show an association between upregulated gene expression of miR103a, tendentially of miR107, and adaptive coping in FMS patients. Validation of this pair of miRNA may enable to identify a somatic resilience factor in FMS.

Citing Articles

Management of Fibromyalgia: Novel Nutraceutical Therapies Beyond Traditional Pharmaceuticals.

Antonelli A, Bianchi M, Fear E, Giorgi L, Rossi L Nutrients. 2025; 17(3).

PMID: 39940388 PMC: 11820827. DOI: 10.3390/nu17030530.

Identifying microRNAs Possibly Implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Review.

Tsamou M, Kremers F, Samaritakis K, Roggen E Int J Mol Sci. 2024; 25(17).

PMID: 39273498 PMC: 11395538. DOI: 10.3390/ijms25179551.

Common miRNAs of Osteoporosis and Fibromyalgia: A Review.

Philippe S, Delay M, Macian N, Morel V, Pickering M Int J Mol Sci. 2023; 24(17).

PMID: 37686318 PMC: 10488272. DOI: 10.3390/ijms241713513.

Berg F, Moser D, Hagena V, Streit F, Mosch B, Kumsta R Genes (Basel). 2023; 14(7).

PMID: 37510217 PMC: 10379154. DOI: 10.3390/genes14071312.

A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia.

Ovrom E, Mostert K, Khakhkhar S, McKee D, Yang P, Her Y Biomedicines. 2023; 11(4).

PMID: 37189737 PMC: 10135661. DOI: 10.3390/biomedicines11041119.

References

Varma G, Sobolewski M, Cory-Slechta D, Schneider J . Sex- and brain region- specific effects of prenatal stress and lead exposure on permissive and repressive post-translational histone modifications from embryonic development through adulthood. Neurotoxicology. 2017; 62():207-217. PMC: 5623619. DOI: 10.1016/j.neuro.2017.07.002. View

Evdokimov D, Frank J, Klitsch A, Unterecker S, Warrings B, Serra J . Reduction of skin innervation is associated with a severe fibromyalgia phenotype. Ann Neurol. 2019; 86(4):504-516. DOI: 10.1002/ana.25565. View

Uceyler N, Riediger N, Kafke W, Sommer C . Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies. J Neurol. 2014; 262(1):203-12. DOI: 10.1007/s00415-014-7556-8. View

Sommer C, Richter H, Rogausch J, Frettloh J, Lungenhausen M, Maier C . A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol. 2011; 11:104. PMC: 3180265. DOI: 10.1186/1471-2377-11-104. View

Sarnico I, Branca C, Lanzillotta A, Porrini V, Benarese M, Spano P . NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. Brain Res. 2012; 1476:203-10. DOI: 10.1016/j.brainres.2012.04.013. View

Song Y, Ma X, Ma G, Lin B, Liu C, Deng Q . MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8. Diagn Pathol. 2014; 9:164. PMC: 4169227. DOI: 10.1186/s13000-014-0164-1. View

Moncini S, Lunghi M, Valmadre A, Grasso M, Del Vescovo V, Riva P . The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer's Disease Pathogenesis. Mol Neurobiol. 2016; 54(6):4329-4342. DOI: 10.1007/s12035-016-0002-4. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Foley N, ONeill L . miR-107: a toll-like receptor-regulated miRNA dysregulated in obesity and type II diabetes. J Leukoc Biol. 2012; 92(3):521-7. DOI: 10.1189/jlb.0312160. View

10.

Ji R, Chamessian A, Zhang Y . Pain regulation by non-neuronal cells and inflammation. Science. 2016; 354(6312):572-577. PMC: 5488328. DOI: 10.1126/science.aaf8924. View

11.

Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, Xie Z . Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun. 2019; 10(1):2145. PMC: 6513984. DOI: 10.1038/s41467-019-10116-0. View

12.

Agarwal V, Bell G, Nam J, Bartel D . Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4. PMC: 4532895. DOI: 10.7554/eLife.05005. View

13.

Olivieri F, Rippo M, Prattichizzo F, Babini L, Graciotti L, Recchioni R . Toll like receptor signaling in "inflammaging": microRNA as new players. Immun Ageing. 2013; 10(1):11. PMC: 3618188. DOI: 10.1186/1742-4933-10-11. View

14.

Goldberg R, PACHAS W, Keith D . Relationship between traumatic events in childhood and chronic pain. Disabil Rehabil. 1999; 21(1):23-30. DOI: 10.1080/096382899298061. View

15.

Bleckmann A, Leha A, Artmann S, Menck K, Salinas-Riester G, Binder C . Integrated miRNA and mRNA profiling of tumor-educated macrophages identifies prognostic subgroups in estrogen receptor-positive breast cancer. Mol Oncol. 2014; 9(1):155-66. PMC: 5528681. DOI: 10.1016/j.molonc.2014.07.023. View

16.

Eisenberger N, Moieni M, Inagaki T, Muscatell K, Irwin M . In Sickness and in Health: The Co-Regulation of Inflammation and Social Behavior. Neuropsychopharmacology. 2016; 42(1):242-253. PMC: 5143485. DOI: 10.1038/npp.2016.141. View

17.

Bohn D, Bernardy K, Wolfe F, Hauser W . The association among childhood maltreatment, somatic symptom intensity, depression, and somatoform dissociative symptoms in patients with fibromyalgia syndrome: a single-center cohort study. J Trauma Dissociation. 2013; 14(3):342-58. DOI: 10.1080/15299732.2012.736930. View

18.

Leinders M, Doppler K, Klein T, Deckart M, Rittner H, Sommer C . Increased cutaneous miR-let-7d expression correlates with small nerve fiber pathology in patients with fibromyalgia syndrome. Pain. 2016; 157(11):2493-2503. DOI: 10.1097/j.pain.0000000000000668. View

19.

Van der Auwera S, Ameling S, Wittfeld K, dHarcourt Rowold E, Nauck M, Volzke H . Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels. Neuropsychopharmacology. 2019; 44(12):2030-2037. PMC: 6898678. DOI: 10.1038/s41386-019-0460-2. View

20.

Hauser W, Kosseva M, Uceyler N, Klose P, Sommer C . Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken). 2010; 63(6):808-20. DOI: 10.1002/acr.20328. View